Blockchain Registration Transaction Record

Salignostics Secures TGA Approval for Saliva-Based Home Pregnancy Test

Salignostics, a leader in innovative saliva-based diagnostic solutions, proudly announces that its revolutionary saliva-based pregnancy test, Salistick, has received approval from Australia’s Therapeutic Goods Administration (TGA). This achievement marks a pivotal step forward for Salignostics, allowing the company to bring its cutting-edge technology to consumers in Australia and New Zealand. Partnering with SGG Solutions, the Australian sponsor for the product, Salignostics is poised to redefine pregnancy testing with its non-invasive, accurate, and user-friendly solution.

This news matters. Salignostics' revolutionary saliva-based pregnancy test, Salistick, has received approval from Australia’s Therapeutic Goods Administration (TGA). This achievement marks a pivotal step forward for the company, allowing it to bring cutting-edge technology to consumers in Australia and New Zealand, redefining pregnancy testing with its non-invasive, accurate, and user-friendly solution. The TGA approval reinforces the safety, quality, and performance of Salistick and represents a gateway to further regulatory approvals, including plans to pursue U.S. FDA clearance in 2025.